Dr. Raj Chovatiya shares his thoughts on the recent approval of ruxolitinib for treatment of vitiligo and where he might use it, either alone or in combination with other vitiligo treatments.
Back
Latest Advances in the Management of Vitiligo
Dr. Raj Chovatiya, MD, PhD, reviews recent FDA approval and how addition of new treatments can improve management of vitiligo going forward.
Latest Advances in the Management of Vitiligo
Episodes
All
All
Advertisement
Advertisement
Trending on HCPLive
1
Half-Life vs. Real Life: How Real-World Evidence Is Reframing Wet AMD Treatment
2
FDA Grants Priority Review for Insmed's ARIKAYCE sNDA for MAC Lung Disease
3
When Innovation Builds Clinical Confidence: Evaluating Treatment Options in Hemophilia A
4
Anaphylm Is Back at the FDA: A Clinician FAQ on Needle-Free Epinephrine
5